Maher Masoud, CEO of MaxCyte Inc, bought 100,000 shares at $4.89, investing $489,000. With a total of 200,000 shares, he has shown confidence in the company's cell engineering technologies.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing